1 enrolling by invitation, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Azoospermia, Nonobstructive: new trials by email Literature Review of Azoospermia, Nonobstructive trials Research Report on Azoospermia, Nonobstructive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm isotretinoin, Human chorionic gonadotrophin (hCG) - Oligospermia, Azoospermia, Nonobstructive | Phase 2 | Enrolling by invitation | University of Nebraska | 100 | 2026-04-13 | 2026-04-20 |
| Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg® Medicinal product MediReg® (Human Mesenchymal Stromal Cell Secretome), lyophilizate for preparation of solution for injection in patients with severe spermatogenesis disorders, Clostilbegit (clomiphene) 50 mg 1 tablet x 1 p a day - 3 months, Triovit - 1 tablet x 1 p a day - 3 months, Folic acid - 1 tablet x 1 p a day - 3 months. - Azoospermia, Nonobstructive, Teratospermia | Phase 1 / Phase 2 | Recruiting | Lomonosov Moscow State University Medical Research and Educational Center | 80 | 2024-11-26 | 2025-03-11 |
| GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia GnRHa/ hCG/ hMG - Azoospermia | Phase 2 | Unknown | Jinling Hospital, China | 30 | 2015-12-01 | 2016-08-02 |
Azoospermia (2) · Oligospermia (2) · Infertility (1) · Infertility, Male (1) · Teratozoospermia (1)
Genital Diseases (3) · Genital Diseases, Male (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Infertility (2) · Infertility, Male (2)
Chorionic Gonadotropin (2) · Injections (2) · Clomiphene (1) · Goserelin (1) · Isotretinoin (1) · Urofollitropin (1)
Jinling Hospital, China (1) · Lomonosov Moscow State University Medical Research and Educational Center (1) · University of Nebraska (1)
China (1) · Russia (1) · United States (1)
Anastasia Efimenko, doctor of sciences (1) · Bing Yao, MD (1) · Chris Deibert, MD, MPH (1) · Dmitry Okhobotov, doctor of sciences (1)